Table 3. Specific types and numbers of mutations found in the different groups.
Groups | Gene | Spec mut. | Type of mut. |
---|---|---|---|
TAM | K-RAS | 14% (4 of 29) | G>A (3 of 4) G>T (1 of 4) |
P53 | 34% (10 of 29) | A>G (2 of 10) A>T (1 of 10) C>T (2 of 10) G>A (1 of 10) G>T (1 of 10) Indel (3 of 10) | |
|
PTEN |
21%
(6 of 29) |
C>T (1 of 6)
Indel (5 of 6) |
EC | K-RAS | 5% (2 of 37) | G>A (1 of 2) T>C (1 of 2) |
P53 | 38% (14 of 37) | A>G (3 of 14) C>T (6 of 14) G>A (1 of 14) T>A (1 of 14) Indel (3 of 14) | |
PTEN | 59% (22 of 37) | A>C (1 of 22) A>G (1 of 22) A>T (2 of 22) C>A (2 of 22) C>G (2 of 22) C>T (4 of 22) G>T (2 of 22) T>A (1 of 22) T>G (1 of 22) T>C (1 of 22) Indel (5 of 22) |
Abbreviations: EC=unexposed to the drug; TAM=tamoxifen.
The number of mutations is based on each individual mutation found in the patients, which includes multiple mutations in the same gene.